UT Health San Antonio
Login

Suryavathi Viswanadhapalli, PhD

Associate Professor

Currently seeking M.S. & Ph.D. students

Subspecialties: Developed EC359 (LIFR inhibitor) and HBS-101 (Midkine inhibitor) for women’s cancers, focusing on therapy resistance and drug development.

Dr. Suryavathi Viswanadhapalli is a passionate cancer researcher and Associate Professor in the Department of Obstetrics and Gynecology at UT Health San Antonio. Her journey began with a Ph.D. in Reproductive Toxicology from the University of Rajasthan, India, followed by postdoctoral training at the University of Virginia, where she explored the genetic roots of infertility and endocrine disorders.

Her scientific path led her to UT Health, where she deepened her expertise in hormonal carcinogenesis and therapy resistance in women’s cancers. Since joining the faculty in 2018, Dr. Viswanadhapalli has been at the forefront of developing and validating targeted therapies for gynecologic cancers.

Her lab focuses on small-molecule drug development, CRISPR/Cas9 functional genomics, and cutting-edge preclinical models like patient-derived organoids and xenografts. With a strong commitment to translational research, she aims to bring innovative, personalized treatments closer to the clinic.